Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Membrane Asymmetry Regulating Transporters01:19

Membrane Asymmetry Regulating Transporters

6.8K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
6.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

4.8K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.8K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

11.6K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.6K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

5.5K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.5K
Insertion of Multi-pass Transmembrane Proteins in the RER01:29

Insertion of Multi-pass Transmembrane Proteins in the RER

17.1K
The rough ER membrane synthesizes, assembles, and embeds transmembrane proteins in diverse topologies. These proteins function as transporters or channels and can remain in the ER membrane or are sent to the Golgi complex, lysosome, and cell membrane.
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
17.1K
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

3.6K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALG14 Variants Contribute to a Congenital Disorder of Glycosylation Characterized by Congenital Myasthenia and Epilepsy.

HGG advances·2026
Same author

A class of deep intronic <i>IGHMBP2</i> variants activate a shared cryptic splice donor, enabling correction of select variants with a single antisense oligonucleotide.

medRxiv : the preprint server for health sciences·2026
Same author

Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disorders.

JCI insight·2026
Same author

Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinism.

bioRxiv : the preprint server for biology·2026
Same author

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Science advances·2026
Same author

A homozygous nonsense variant in the oligosaccharyltransferase complex gene, RPN1, causes a congenital disorder of glycosylation.

HGG advances·2026

Related Experiment Video

Updated: Dec 21, 2025

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
06:45

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay

Published on: May 26, 2011

15.5K

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway.

Mitali A Tambe1, Bobby G Ng1, Shino Shimada2

  • 1Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.

Journal of Inherited Metabolic Disease
|May 13, 2020
PubMed
Summary

This study identifies the first individual with GET4 mutations, impacting the transmembrane domain recognition complex (TRC) and tail-anchored protein targeting. Treatment with bortezomib restored protein localization and TRC levels.

Keywords:
BAG6GET4GET5TRC pathwaycongenital disorders of glycosylationsyntaxin 5

More Related Videos

Reconstitution of Msp1 Extraction Activity with Fully Purified Components
05:52

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Published on: August 10, 2021

2.8K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.7K

Related Experiment Videos

Last Updated: Dec 21, 2025

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
06:45

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay

Published on: May 26, 2011

15.5K
Reconstitution of Msp1 Extraction Activity with Fully Purified Components
05:52

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Published on: August 10, 2021

2.8K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.7K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The transmembrane domain recognition complex (TRC), comprising GET4, BAG6, and GET5, is crucial for targeting tail-anchored (TA) proteins to cellular membranes.
  • Proper localization of TA proteins is essential for organelle function, including protein transport between the endoplasmic reticulum (ER) and Golgi apparatus.

Observation:

  • A patient with compound heterozygous missense variants in GET4 exhibited significantly reduced levels of all three TRC proteins in fibroblasts.
  • This reduction led to impaired targeting of the TA protein syntaxin 5 to Golgi membranes and disrupted retrograde ER to Golgi transport.

Findings:

  • Patient fibroblasts showed decreased syntaxin 5 localization and reduced retrograde transport, consistent with TRC complex dysfunction.
  • Increased degradation of TRC proteins, not altered mRNA levels, was indicated as the cause of reduced protein abundance.
  • Treatment with bortezomib, a proteasome inhibitor, normalized syntaxin 5 localization and TRC protein levels in patient fibroblasts.

Implications:

  • This research identifies the first human genetic disorder linked to mutations in GET4, a key component of the TRC complex.
  • The findings highlight the critical role of GET4 in TA protein targeting and ER-Golgi transport, and suggest therapeutic potential for proteasome inhibitors in related disorders.